{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:51:27Z","timestamp":1774313487520,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To determine the survival and prognostic factors of patients with primary fallopian tube cancer (<jats:styled-content style=\"fixed-case\">PFTC<\/jats:styled-content>) who had been treated with paclitaxel and carboplatin chemotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The records of patients with <jats:styled-content style=\"fixed-case\">PFTC<\/jats:styled-content> who had been treated between 2002 and 2010, identified through the report of <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>hiang <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>ai <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>niversity <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>ospital, were reviewed. All patients had pathological materials initially reported or reviewed by a gynecologic pathologist before initiation of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty patients met the inclusion criteria. Median age was 51 years. Serous adenocarcinoma was observed in the majority of patients (76.7%). Approximately 46% of patients were in stage <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>. The 5\u2010year progression\u2010free survival (<jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content>) for all patients was 37.2%. The 5\u2010year <jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content> was 75.0% for stage <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>, 51.4% for stage <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content> and 18.5% for stage <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content>. Median <jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content> of the entire cohort was 26.0 months with a 95% confidence interval (<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) of 18.7\u201333.3 months. This rate was 18.5 months (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 6.7\u201335.6) for stage <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content> whereas it was not reached for patients of stage <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>. Serous histology and stage were noted to be significant independent predictors of <jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content> with an adjusted hazards ratio of 7.54 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 1.34\u201342.4) and 6.19 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 1.59\u201324.08), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The 5\u2010year <jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content> of the whole cohort was 37.2% with a median survival of 26 months. <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>nternational <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>ederation of <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>ynecology and <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>bstetrics stage and histological subtype were a significant independent factor for predicting <jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jog.12241","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T06:00:32Z","timestamp":1385445632000},"page":"806-811","source":"Crossref","is-referenced-by-count":3,"title":["Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy"],"prefix":"10.1111","volume":"40","author":[{"given":"Chumnan","family":"Kietpeerakool","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatupol","family":"Srisomboon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supareuk","family":"Phongsaranantakul","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surapan","family":"Khunamornpong","sequence":"additional","affiliation":[{"name":"Department of Pathology Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chalong","family":"Cheewakriangkrai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narisa","family":"Sribanditmongkol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Faculty of Medicine Chiang Mai University  Chiang Mai Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/01443610500292395"},{"key":"e_1_2_6_3_1","first-page":"1338","article-title":"Primary carcinoma of the fallopian tube: A clinicopathologic analysis of 27 patients","volume":"88","author":"Kietpeerakool C","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/01443610701811894"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5623"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6095"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/mp.55.5.305"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.18.1365"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn442"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6012"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2006.05.014"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-008-0767-1"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.06.025"},{"key":"e_1_2_6_14_1","volume-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"World Health Organization","year":"1979"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1545"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5267"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6134"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2002.6743"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.2001.011001069.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2011.01.031"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.05.016"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjog.12241","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjog.12241","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.12241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T14:45:42Z","timestamp":1696171542000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/jog.12241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1111\/jog.12241"],"URL":"https:\/\/doi.org\/10.1111\/jog.12241","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}